by TractManager | May 19, 2023 | Emerging Technology Report
The Reducer (Shockwave Medical Inc.) is a catheter-delivered, hourglass-shaped, stainless steel mesh device implanted into the coronary sinus to improve blood flow to ischemic myocardial tissue in patients with refractory angina pectoris who are unsuitable for...
by TractManager | May 19, 2023 | Emerging Technology Report
The Revivent TC Transcatheter Ventricular Enhancement System is a micro-anchor and tether system intended for minimally invasive left ventricular (LV) restoration in patients with LV scar/aneurysm and heart failure.If you have a Hayes login, click here to view the...
by TractManager | May 18, 2023 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of dry needling (DN) compared with standard therapies to treat chronic pain of the neck or upper trapezius in adults.Technology Description: DN (also called...
by TractManager | May 18, 2023 | Emerging Technology Report
VE303 is an investigational oral microbiome restoration therapy proposed to prevent recurrent Clostridioides difficile infection (CDI) in adults following antibacterial treatment for CDI.If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | May 17, 2023 | Emerging Technology Report
Veozah is an NK3 receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments